drugset / Trial / NCT02416427
Targeting the Hippo Transducer TAZ in Breast Cancer With Statins
RandomizedParallel-groupOpen-labelTreatment
Summary
This pre-surgical, window-of-opportunity study is designed to investigate whether atorvastatin reduces the proliferation marker Ki-67 via modulation of the Hippo transducer TAZ.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | — |